Us Cardiac Markers Point-of-care Detection Market Size By Applications, By Type, By End-User, By Deployment & By Technology 2032
Cardiac Markers Point-of-care Detection Market was valued at USD 1.5 Billion in 2022 and is projected to reach USD 3.0 Billion by 2030, growing at a CAGR of 9.0% from 2024 to 2030.
The US cardiac markers point-of-care detection market is experiencing significant growth as healthcare professionals seek faster, more efficient ways to diagnose cardiovascular conditions. This demand is driven by the need for rapid decision-making in emergency situations, where time-sensitive interventions can make a significant difference in patient outcomes. Point-of-care (POC) testing for cardiac markers allows for immediate detection of critical biomarkers such as troponin, creatine kinase-MB (CK-MB), and B-type natriuretic peptide (BNP), offering invaluable insights into conditions like heart attacks, congestive heart failure, and other cardiac emergencies.
With the increasing prevalence of cardiovascular diseases in the US, the market for cardiac markers POC detection is poised for expansion. The growing adoption of home-based testing and advancements in miniaturized diagnostics are enabling individuals to monitor their heart health more effectively. The technology’s appeal lies in its ability to provide rapid, reliable results outside traditional laboratory settings, often within minutes, empowering healthcare providers to take immediate action. This shift is also aligned with a broader trend towards patient-centric care, where patients are given greater control and convenience over their diagnostic processes.
Statistical data shows that the US cardiac markers point-of-care detection market is expected to grow at a compounded annual growth rate (CAGR) of 8% from 2023 to 2030. Key drivers include an aging population, an increasing number of hospitalizations due to heart-related conditions, and growing awareness about the importance of early detection in cardiovascular health. Additionally, partnerships between diagnostic companies and healthcare providers are accelerating the deployment of innovative testing devices, further fueling the market’s expansion.
Technology advancements, such as the integration of 100 Gigabit Fiber Optic Transceiver Market technologies into cardiac diagnostics, promise to enhance data transmission speeds and precision, improving the reliability of test results and overall healthcare system efficiency. As the market evolves, the role of digital health solutions, artificial intelligence, and machine learning will become increasingly prominent in optimizing the accuracy and speed of point-of-care testing devices, ultimately benefiting both patients and healthcare providers alike.
Furthermore, regulatory approvals and the development of portable, cost-effective POC devices are expected to stimulate the market. With these advancements, cardiac marker testing is set to become a cornerstone of cardiovascular care in emergency settings, providing the critical insights needed for timely interventions. These trends suggest that the US cardiac markers point-of-care detection market will continue to thrive as demand for immediate and reliable diagnostic tools grows.
Get an In-Depth Research Analysis of the Global Cardiac Markers Point-of-care Detection Market Size And Forecast [2025-2032]
Alere
Roche
Abbott
BioMérieux
LSI Medience Corporation
Randox laboratories Ltd
Guangzhou Wondfo Biotechnology Co.
Ltd.
Getein Biotech
ReLIA
Lepu Medical
Goldsite
Lifotronic
Hotgen
Ediagnosis
POCT
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Cardiac Markers Point-of-care Detection Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Cardiac Markers Point-of-care Detection Market
Cardiac Biomarkers
Portable Testing Devices
Emergency Care Tests
Routine Screening Tests
Risk Stratification Tests
Hospitals
Diagnostic Laboratories
Home Care Settings
Ambulatory Surgical Centers
Cardiac Rehabilitation Centers
Acute Myocardial Infarction
Heart Failure Diagnosis
Post-operative Cardiac Complications
Risk Assessment for Cardiac Diseases
Immunoassay Technology
Electrochemical Detection
Microfluidics
Nanotechnology-based Testing
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Cardiac Markers Point-of-care Detection Market Research Analysis
1. Introduction of the Global Cardiac Markers Point-of-care Detection Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Cardiac Markers Point-of-care Detection Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Cardiac Markers Point-of-care Detection Market, By Type
6. Global Cardiac Markers Point-of-care Detection Market, By Application
7. Global Cardiac Markers Point-of-care Detection Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Cardiac Markers Point-of-care Detection Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/